The MDS Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The MDS Channel on VJHemOnc is supported by Bristol Myers Squibb,Gilead Oncology,Geron, Syros Pharmaceuticals and Curis Inc.. This supporter has no influence over the production of the content.

Welcome to The Myelodysplastic Syndromes (MDS) Channel

Explore all things new and exciting in MDS, with exclusive insights, must-know news, and unique expert perspectives, courtesy of The MDS Channel.

Much research is underway to address the paucity of available options in MDS and many new agents, targets, and treatment approaches are in development or under investigation, such as novel HMA-based combinations, immunotherapies, and other newer agents. With the support of a world-leading Editorial Board, VJHemOnc brings you informative interviews, roundtable discussions, feature articles, and podcasts; a one-stop source for the key MDS news!


BSH 2023
ASH 2022
SOHO 2022
EHA 2022
ASCO 2022
Tandem Meetings 2022


Trial Updates
Disease Biology

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter